ANRESIS, the Swiss Centre for Antibiotic Resistance is a nationwide, representative surveillance system and research instrument for antibiotic resistance and consumption. It is led by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.
ANRESIS was present at this year's ESCMID Global congress with posters on the WHO target of 60% Access group antibiotics reached by Switzerland (https://www.anresis.ch/wp-content/uploads/2024/04/240416_ECCMID244_Pluess-Suard.pdf) and on extended-spectrum cephalosporin resistances during the COVID-19 pandemic (https://www.anresis.ch/wp-content/uploads/2024/04/2024_eccmid_poster_covid_escr.pdf).
ANRESIS was featured in the SRF - Schweizer Radio und Fernsehen daily News Plus podcast on the topic "Antibiotic resistance: how big is the problem in Switzerland?"
📰Aktuell in der Schweizerischen Ärztezeitung: ANRESIS stellt sich und seine neuen Tools vor! Wie wir die Ärzteschaft mit dem ANRESIS-guide und weiteren Anwendungen beim richtigen Einsatz von Antibiotika unterstützen
https://www.anresis.ch/wp-content/uploads/2024/02/2024-SAEZ_ANRESIS.pdf
ANRESIS continuously collects all anonymized resistance data that is generated in routine diagnostics from
ANRESIS is supported by the following Organisations
